skip to Main Content

EASL is an association dedicated to the pursuit of excellence in liver research and in the clinical practice of liver disorders. EASL is governed by a board: the Secretary General, Vice-Secretary, Treasurer, five Scientific Committee members, two Educational Councillors, an EU Policy Councillor, and the Executive Director of EASL.

EASL_GB_Prof. Tom Hemming Karlsen

EASL SECRETARY GENERAL

Prof. Tom Hemming Karlsen, MD, PhD, graduated from medical school at the University of Bergen in 1997. Within the Division of Cancer Medicine, Transplantation and Surgery at the Oslo University Hospital he is leader of the Norwegian PSC research center at the Department of Transplantation Medicine, as well as the Section of Molecular Hepatology at the Research Institute of Internal Medicine; altogether comprising three research groups (Experimental liver research, Genomics and metagenomics in inflammatory disorders, and a clinical research group).

EASL VICE-SECRETARY

Prof. Philip N. Newsome, director of the Centre for Liver Research & Professor of Experimental Hepatology, University of Birmingham, and Consultant Hepatologist at the Liver Unit, Queen Elizabeth Hospital, BirminghamHe graduated from the Medical School at the University of Edinburgh in 1995 and moved to Birmingham in 2007.He runs the metabolic services at the Liver Unit at the Queen Elizabeth Hospital Birmingham which includes a large multi-disciplinary clinic for patients with NAFLD. Professor Newsome has published over 75 research papers in scientific journals as well as many book chapters in the field of Non-Alcoholic Fatty Liver Disease (NAFLD). He was Chief Investigator on a randomised controlled trial of Glucagon-like peptide-1 (GLP-1) therapy in NAFLD published in the Lancet, and is also Chief Investigator on a study of Fibroscan in NAFLD. He is editor of a recently published textbook on Liver Transplantation, and chaired the national guidelines for liver transplantation in NAFLD. He sits on the NICE Guideline Development Group for NAFLD.

EASLGB-Prof. Mauro Bernardi

EASL TREASURER

Prof. Mauro Bernardi, MD, graduated in Medicine at the University of Bologna in 1972. He completed his residency in Gastroenterology and then Internal Medicine at the Universities of Bologna and Chieti from 1972 to 1978.

He was appointed as Assistant Professor in Internal Medicine at Chieti (1974-1978) and Bologna Universities (1978-1983). He spent 1975 in the Liver Research Unit of King’s College Hospital, London (Prof. R. Williams), as a locum research fellow, where he started his research activity on renal function abnormalities in cirrhosis under the guidance of Dr. S.P. Wilkinson.

EASL GB member Prof. Francesco Negro

Prof. Francesco Negro is now Treasurer-elect and will be shadowing Prof. Mauro Bernardi for the following year (until April 2019)

Professor Francesco Negro obtained his MD degree at the University of Torino, Italy, in 1982. He then received research training at the University of Georgetown, Rockville, MD, where he became Assistant Professor in 1989, and then at the National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD. He is currently Full Professor at the Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospital of Geneva, Switzerland.

Professor Negro has served in the editorial board of several international journals in the field of hepatology, and is currently Co-Editor of Liver International. He has also developed the iLiver application for the European Association for the Study of the Liver.

EASL GB member Prof. Helena Cortez-Pinto

EU POLICY COUNCILLOR

Prof. Helena Cortez-Pinto, MD, PhD, graduated from the Faculty of Medical Sciences of Lisbon, in 1981. Between 1985 and 1990, she did her internship in Gastroenterology in the University Hospital of Santa Maria.

In 1998, she did a research fellowship during 6 months, on Anna Mae Diehl Lab, in Johns Hopkins University, investigating in the area of Non-alcoholic fatty liver disease. In 2000, she presented her PhD entitled “Steatosis and non-alcoholic steatohepatitis. Clinical aspects and pathogenic mechanisms”.

EASL SCIENTIFIC COMMITTEE MEMBERS

EDUCATIONAL COUNCILLORS OF EASL